In a report released yesterday, Jason Mills from Canaccord Genuity maintained a Buy rating on Intuitive Surgical (ISRG), with a price target of $562.00. The company’s shares closed last Thursday at $510.44.
According to TipRanks.com, Mills is a top 100 analyst with an average return of 20.6% and a 66.1% success rate. Mills covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Staar Surgical Company, and Merit Medical Systems.
Currently, the analyst consensus on Intuitive Surgical is a Moderate Buy with an average price target of $560.36, an 8.8% upside from current levels. In a report issued on April 1, Goldman Sachs also downgraded the stock to Buy with a $587.00 price target.
See today’s analyst top recommended stocks >>
Intuitive Surgical’s market cap is currently $59.59B and has a P/E ratio of 44.30. The company has a Price to Book ratio of 7.61.
Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ISRG in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Read More on ISRG: